当前位置：
X-MOL 学术
›
BMC Complement. Altern. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A bioinformatics investigation into the pharmacological mechanisms of the effect of the Yinchenhao decoction on hepatitis C based on network pharmacology.
BMC Complementary and Alternative Medicine ( IF 4.782 ) Pub Date : 2020-02-12 , DOI: 10.1186/s12906-020-2823-y Jingyuan Zhang 1 , Xinkui Liu 1 , Jiarui Wu 1 , Wei Zhou 1 , Jinhui Tian 2 , Siyu Guo 1 , Shan Shan Jia 1 , Ziqi Meng 1 , Mengwei Ni 1
BMC Complementary and Alternative Medicine ( IF 4.782 ) Pub Date : 2020-02-12 , DOI: 10.1186/s12906-020-2823-y Jingyuan Zhang 1 , Xinkui Liu 1 , Jiarui Wu 1 , Wei Zhou 1 , Jinhui Tian 2 , Siyu Guo 1 , Shan Shan Jia 1 , Ziqi Meng 1 , Mengwei Ni 1
Affiliation
BACKGROUND
Globally, more than 170 million people are infected with hepatitis C virus, a major cause of cirrhosis and hepatocellular carcinoma. The Yinchenhao Decoction (YCHD) is a classic formula comprising three herbal medicines. This decoction have long been used in China for clinically treating acute and chronic infectious hepatitis and other liver and gallbladder damp heat-accumulation disorders.
METHODS
In this study, we identified 32 active ingredients and 200 hepatitis C proteins and established a compound-predicted target network and a hepatitis C protein-protein interaction network by using Cytoscape 3.6.1. Then, we systematically analyzed the potential targets of the YCHD for the treatment of hepatitis C. Finally, molecular docking was applied to verify the key targets. In addition, we analyzed the mechanism of action of the predicted targets by the Kyoto Encyclopedia of Genes and Genomes and gene ontology analyses.
RESULTS
This study adopted a network pharmacology approach, mainly comprising target prediction, network construction, module detection, functional enrichment analysis, and molecular docking to systematically investigate the mechanisms of action of the YCHD in hepatitis C. The targets of the YCHD in the treatment of hepatitis C mainly involved PIK3CG, CASP3, BCL2, CASP8, and MMP1. The module and pathway enrichment analyses showed that the YCHD had the potential to influence varieties of biological pathways, including the TNF signaling pathway, Ras signaling pathway, PI3K-Akt signaling pathway, FoxO signaling pathway, and pathways in cancer, that play an important role in the pathogenesis of hepatitis C.
CONCLUSION
The results of this study preliminarily verified the basic pharmacological effects and related mechanisms of the YCHD in the treatment of hepatitis C.
更新日期：2020-03-28
京公网安备 11010802027423号